Literature DB >> 3091379

Immunoglobulin heavy chain gene rearrangements in X-linked agammaglobulinemia.

E J Mensink, R K Schuurman, J D Schot, A Thompson, F W Alt.   

Abstract

X-linked agammaglobulinemia (XLA) appears to involve a defect in human B lymphocyte differentiation which is manifested at the pre-B cell stage. The defect segregates as an X-linked recessive trait but is not a single genetic entity. IgM-producing B cell clones were established by Epstein-Barr virus transformation of peripheral blood mononuclear cells of patients with the XLA defect linked to the DXS3 and DXS17 chromosomal loci. Individual XLA B cell clones were demonstrated to have rearrangements of the JH regions of both immunoglobulin VH region loci. The rearranged JH regions of the B cell clone ALA 19 were molecularly cloned and their nucleotide sequence was determined. Both JH-associated rearrangements (designated 191 and 192) resulted from the juxtaposition of variable (VH), diversity (D) and joining (JH) segments (VHDJH rearrangements). The 191 rearrangement employed a VH segment belonging to VH subgroup III and a JH4 segment. The 192 rearrangement employed a VHII and a JH6 segment. The D191 and D192 segments encompassed 21 and 28 nucleotides, respectively, and showed little homology to each other or to previously reported human D sequences. Surprisingly, both VHDJH complexes had open reading frames. However, in accord with principles of allelic exclusion, only the 191 allele was detectably expressed in the total RNA of the cell. A possible mechanism for the lack of expression of the 192 allele is discussed. We conclude that the DXS3-DXS17-linked XLA defect does not preclude VH to DJH rearrangements or the expression of VH containing heavy chain molecules.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091379     DOI: 10.1002/eji.1830160815

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

Review 1.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  Internalization of MHC class I molecules is a prerequisite for endocytosis of endorphin by lymphocytes.

Authors:  A M Mommaas; M C Wijsman; W Verduijn; B J Vermeer; F M Claas
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

3.  Immunoglobulin variable heavy chain cDNA sequence from a patient with X-linked agammaglobulinemia.

Authors:  F Mortari; H D Ochs; R J Wedgwood; H W Schroeder
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

4.  Evidence for failure of V(D)J recombination in bone marrow pre-B cells from X-linked agammaglobulinemia.

Authors:  J Schwaber
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

Review 5.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

6.  Discordant phenotype in siblings with X-linked agammaglobulinemia.

Authors:  M J Bykowsky; R N Haire; Y Ohta; H Tang; S S Sung; E S Veksler; J M Greene; S M Fu; G W Litman; K E Sullivan
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

7.  Evidence for male X chromosomal mosaicism in X-linked agammaglobulinemia.

Authors:  R W Hendriks; E J Mensink; M E Kraakman; A Thompson; R K Schuurman
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

Review 8.  BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future.

Authors:  M Spaargaren; M F M de Rooij; A P Kater; E Eldering
Journal:  Oncogene       Date:  2014-06-23       Impact factor: 9.867

9.  Antisera to human IgE can also recognize IgA and IgM molecules as produced by selected B lymphoblastoid cell lines.

Authors:  R W Hendriks; A Thompson; M E Kraakman; A L Drayer; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

10.  Premature termination of variable gene rearrangement in B lymphocytes from X-linked agammaglobulinemia.

Authors:  J Schwaber; R H Chen
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.